- Solid Biosciences Inc at JPMorgan Healthcare Conference TranscriptJan 11, 2024
- Solid Biosciences Inc at Citi BioPharma Conference TranscriptSep 07, 2023
- Solid Biosciences Inc at Barclays Virtual Gene Editing & Therapy Summit TranscriptMay 24, 2023
- Solid Biosciences Inc at JMP Securities Life Sciences Conference TranscriptMay 15, 2023
- Solid Biosciences Inc at Chardan Genetic Medicines & Cell Therapy Manufacturing Summit (Virtual) TranscriptApr 24, 2023
- Solid Biosciences Inc at Needham Healthcare Conference (Virtual) TranscriptApr 20, 2023
- Solid Biosciences Inc at BMO Capital Markets BioPharma Spotlight Series: Genetic Medicine Delivery (Virtual) TranscriptMar 28, 2023
- Solid Biosciences Inc at Barclays Global Healthcare Conference TranscriptMar 14, 2023
- Solid Biosciences Inc at JPMorgan Healthcare Conference TranscriptJan 12, 2023
- Solid Biosciences Inc To Acquire Aavantibio Inc Call TranscriptSep 30, 2022
- Q1 2022 Solid Biosciences Inc Earnings Call TranscriptApr 27, 2022$9.65 (-16.98%)Earnings
- Solid Biosciences Inc at JPMorgan Healthcare Conference (Virtual) TranscriptJan 13, 2022
- Solid Biosciences Inc at Jefferies Gene Therapy/Editing Summit (Virtual) TranscriptOct 28, 2021
- Solid Biosciences Inc at Chardan Genetic Medicines Conference (Virtual) TranscriptOct 05, 2021
- Q1 2021 Solid Biosciences Inc Earnings Call TranscriptMay 14, 2021$52.35 (-21.40%)Earnings
- Pfizer Inc, Avidity Biosciences, Sarepta Therapeutics, Solid Biosciences, and Ultragenyx Pharmaceutical at Guggenheim Partners Healthcare Talks: Genomic Medicines & Rare Disease (Virtual) TranscriptApr 01, 2021
- Solid Biosciences Inc. - Special Call TranscriptMar 15, 2021
- Solid Biosciences Inc at Barclays Global Healthcare Conference (Virtual) TranscriptMar 11, 2021
- Solid Biosciences Inc at JPMorgan Healthcare Conference (Virtual) TranscriptJan 14, 2021
- Q3 2020 Solid Biosciences Inc Earnings Call TranscriptNov 05, 2020$48.6Earnings
- Solid Biosciences Inc Annual Shareholders Meeting TranscriptJun 16, 2020
- Solid Biosciences Inc. - Special Call TranscriptDec 18, 2019
- Solid Biosciences Inc. - Special Call TranscriptNov 12, 2019
Q1 2021 Solid Biosciences Inc Earnings Call Transcript
Ladies and gentlemen, thank you for standing by, and welcome to the Solid Biosciences Update Call. (Operator Instructions) Please be advised that today's conference is being recorded. I would now like to hand the conference over to your speaker today, Mr. Tim Palmer, Corporate Communications Manager at Solid Biosciences. Sir, you may begin.
Good morning. Thank you, operator.
Before we get started, I would like to remind everyone that during this conference call, we may make forward-looking statements, including statements about the company's financial results, financial guidance, future business strategies and operations and product development and regulatory progress, including statements about the ongoing IGNITE DMD clinical trial. Actual results could differ materially from those discussed in these forward-looking statements due to a number of important factors, including uncertainty inherent in the clinical development and regulatory process, the extent and duration of the impact
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)